Effects of long-term omega-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: Results from a prospective randomised study-Reference-Cited by-同舟云学术

Effects of long-term omega-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: Results from a prospective randomised study

Published:2013-10 Issue:4 Volume:168 Page:3812-3817
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Kumar Saurabh,Sutherland Fiona,Stevenson Irene,Lee Justin M.S.,Garg Manohar L.,Sparks Paul B.

Funder

National Health and Medical Research Council

National Heart Foundation of Australia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Atrial fibrillation after DDDR pacemaker implantation;Gillis;J Cardiovasc Electrophysiol,2002

2. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias;Saksena;Am Heart J,2007

3. Atrial remodeling in varying clinical substrates within beating human hearts: relevance to atrial fibrillation;Kumar;Prog Biophys Mol Biol,2012

4. Long chain n−3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model;Laurent;Cardiovasc Res,2008

5. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling;Sakabe;Circulation,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are the ratio and amount of n-6 and n-3 fatty acids associated with cardiovascular outcomes?—a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials;Food Bioscience;2024-06

2. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

3. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

4. Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT;Journal of the American Heart Association;2023-03-07

5. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease;Cochrane Database of Systematic Reviews;2020-02-29